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A B S T R A C T
Acute coronary syndrome (ACS) presents today the leading group of post-operative cardiovascular complications,
while endothelial dysfunction (ED) is one of the key elements in its development. The chronic ED represents thus the ba-
sis for the gradual development of atherosclerotic changes, while its sudden aggravation leads to ACS. The persistent
ED occurs due to the effects of chronic cardiovascular risk factors, while according to the available studies it can also de-
velop or aggravate under the impact of different acute events. We have directed this study to the investigation of the dy-
namic of endothelial function before and after a major orthopaedic surgical intervention. This randomised prospective
study included 19 patients that underwent the intervention of total knee replacement and 20 healthy examinees of the ad-
equate age and gender. High-resolution ultrasound test based on the flow mediated dilatation of the brachial artery is
what at we carried out at the beginning of the research, respectively 12, 24 48 and 72 hours, as well as 7 days after the
surgical intervention. The starting values of the FMD test were within the normal range in both groups, although the
ability of dilatation upon stimulus was significantly lower in the investigated group. The FMD percentage change in the
total sample was negatively connected with the body weight, not having shown additional connections with other cardio-
vascular risk factors. During the early post-operative period, a significant transitory lowering of the FMD percentage
change was recorded, having reached the lowest value 24 hours after the surgery. During the seven-day prospective sur-
veillance, no significant cardiovascular complications were recorded. Further research is necessary in order to confirm
these results as well as the testing of the possible connection of the described post-operative transitory endothelial dys-
function with the development of cardiovascular complications and the adverse event.
Key words: endothelial dysfunction, flow mediated dilatation, acute coronary syndrome, total knee replacement,
postoperative complications
Introduction
The increase in life expectancy, present in developed
countries in the last decades, has a significant impact on
the overall health issue and the priorities of public health,
but also on the interests of science.
The trend of rise in prevalence of degenerative dis-
eases of the locomotor system and the accompanying rise
in the number of orthopaedic surgical interventions are
in direct connection with the aging of population. Thus,
the number of interventions relating to the total knee re-
placement in the USA from the year 1976 to 2008 has in-
creased seven times1, while this number has tripled in
the Netherlands in the period from the year 1996 to
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20052. At the same time, increased average age also
means having a higher prevalence of cardiovascular dis-
eases, which have remained among the leading medical
problems in general in spite of the modern methods of
treatment3. Nowadays, cardiovascular diseases also have
significant impact on the progression and outcome of ma-
jor orthopaedic surgical interventions. The routine use of
low molecular weight heparin in orthopaedic surgery has
almost eradicated the occurrence of pulmonary thrombo-
embolism, which earlier used to be the most common
non-surgical complication4. Its place has been taken by
the acute coronary syndrome (ACS)5, which involves un-
stable angina pectoris, ST-elevation myocardial infarc-
tion and non ST-elevation myocardial infarction6. The
basis of ACS is regularly manifested by the chronic ath-
erosclerosis of coronary arteries with the occurrence of
acute changes. Although the said relationship is univer-
sal and often does not offer a possibility to identify the
actual trigger for the acutisation of atherosclerotic event,
inflammatory transformation and destabilisation of athe-
rosclerotic plaque is the basis of ACS7–9. Nowadays, we
know that the development of endothelial dysfunction
(ED) has a key role in the progression of chronic athe-
rosclerotic disease, but also in the development of the
acute atherosclerotic plaque. In this process, its insofar
hard and stable capsule becomes soft, unstable and prone
to disruption10. The rupture of destablised atherosclero-
tic plaque leads into the development of acute thrombo-
sis of the affected coronary artery, which presents the an-
atomic basis for the clinical picture of ACS11. The ge-
neralised neurohumoral reaction of the body to different
events, thus also to surgery as a major stressful event,
can present one of the incentives for the development of
ED that then leads to ACS12. The basic characteristics of
endothelins are their generalising quality and functional
unity. The normal function of endothelins confirmed at
the peripheral artery indicates thus the normal global
endothelic as well as coronary function, while the estab-
lishment of an individual function of the endothelin
(vasoreactivity, coagulational, inflammatory or prolifera-
tic status) speaks of its general functional status, which,
as it is the case with the light bulb switch, can only be
twofold, namely, normal or pathological13,14. Although we
still do not have the method of evaluating endothelial
function that would be fully applicable for a routine clini-
cal practice15, the most widely used method today is the
indirect evaluation of availability of nitric oxide (NO), as
the most important endothelial mediator, by the flow me-
diated dilatation test of the brachial artery16.
The risk of ACS in the early post-operative period is
estimated in major prospective studies to around 6%17,18,
however, its incidence is significantly different depend-
ing on the applied diagnostic criteria and the examined
group of patients19. Today we know that diagnosing ACS
in the early period after the surgical intervention bears
certain specific features and limitations with regard to
the general population. Only 16% of patients that de-
velop myocardial infarction (MI) during or after the sur-
gery complain of pains in the chest, while only a half
mentions another symptom16. The said is explained by
the specific conditions in the period around major surgi-
cal interventions, standard application of analgesics and
sedatives as well as the lowered ability of the patient to
notice and indicate symptoms.
The modern definition of MI points out that it is the
clinical event that occurs as a consequence of ischemia
induced necrosis of cardiomyocytes that has to be proved
by a combination of diagnostic criteria, the presence of
subjective disturbances, electrocardiographic changes and
the establishment of specific biochemical markers20. As
the greatest part of data on perioperational incidence of
MI results from the period preceding the routine applica-
tion of sensitive troponin tests, its development is proba-
bly more frequent than the data indicated by the avail-
able studies, while the exact incidence still needs to be
investigated.
The determination of the hazard of development of
cardiovascular complications in each of the most fre-
quent surgical interventions is necessary for today’s clin-
ical practice21,22. Besides major prospective studies that
are needed for this, the above said also involves a better
acquaintance with the actual mechanisms of occurrence
of acute vascular events in the early period after the sur-
gical interventions23.
According to the available data, the ACS development
in the early post-operative period today has a significant
impact on the long-term outcome of surgical treatment24,
the length of hospital stay and total costs of the health
care system. In up-to-date surgery, the post-operative
ACS has thus imposed itself as a new priority in diagnos-
tics, treatment and prevention, so that a great interest
directed to the research of mechanisms of its develop-
ment is not surprising25,26. Although ED is the key event
in the development of ACS, its dynamics in the period
following surgical interventions has so far been poorly
studied, while in the field of major surgical interventions
that present the ever greater part of elective surgical in-
terventions, it has hardly been investigated at all.
Material and Methods
Patients
A total of 39 patients took part in the study, out which
there were 26 women. In the experimental group there
were 19 patients (15 women), while in the control 20 (11
women, p=0.213). Groups of patients did not vary ac-
cording to the age, height, weight and values of measured
blood pressure, but cholesterol levels were statistically
significantly higher in the studied group (Table 1). The
representation of permanent medicament therapy (beta-
-blockers, statins and ACE-inhibitors) did also not vary
between groups (all p>0.05).
Nonselected patients were included in the study, who,
according to the clinical presentation order, underwent
the total knee replacement surgery at the Orthopedic
Clinic Hospital Lovran during the month of October in
the year 2010, as well as a group of healthy examinees of
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the adequate age and gender who responded to the public
call for a check-up. All surgical interventions were made
with the use of tourniquet, according to the standard
protocols of the Good Clinical Practice.
The study did not include patients with the unstable
angina pectoris or suspicion of acute coronary syndrome,
cardiac decompensation, uncontrolled (acute diabetic com-
plications, uncorrected diseases of the thyroid gland),
manifest peripheral vascular disease, active infectious or
other inflammatory diseases including inflammatory dis-
eases of connective tissue, unregulated diabetics (glyco-
lised haemoglobin 7.0 %), smokers, women in the gener-
ative age and patients above the age of 80. During the
study time, all patients were clinically followed at a per-
manent basis, with electrocardiograph analysis made
and troponin I in plasma measured on the daily basis.
Ethical principles
All those involved in the study gave their written per-
mission for participation in this research programme,
previously approved by the ethics committee of the Lov-
ran Clinic for Orthopaedic Surgery and the School of
Medicine of the University of Rijeka.
FMD test
Before the surgical intervention and 1, 24, 48 and 72
hours and 7 days after the intervention, the assessment
of endothelial function was made by high-resolution ul-
trasound flow mediated brachial artery dilatation mea-
surement according to the leading guidelines for its per-
forming and interpretation16. The examination was per-
formed on the ultrasound apparatus SonoSite NanoMaxx
multifrequent (6–13 MHz) with a linear probe at the fre-
quency of 11 MHz, with the simultaneous electrocardio-
graph recording, in a quiet and dark space.
Prior to each examination, a prescribed preparation
of the patient was performed, while measurements were
made on the brachial artery of the dominant arm, in B
mode during the diastole. First, we measured the initial
diameter of the brachial artery, and then had the sphyn-
gomanometer cuff inflated on the brachium of the tested
arm up to the value of pressure that was 50 mmHg
higher than the systolic blood pressure. The compression
was maintained for 5 minutes, after which the change in
the diameter of the tested artery was measured in longi-
tudinal view for 2 minutes after deflation. The difference
of maximal and initial diameter was expressed in the
FMD percentage change. Upon the completion of the
FMD test, with a minimally ten-minute long pause, we
investigated nitroglycerin mediated dilatation on the ap-
plication of glycerol nitrate in the dose of 400 mg sublin-
gually by measuring the diameter of the same artery for
four minutes upon the application. All examinees whose
NMD test results were below the referent values were ex-
cluded from further research due to the supposed non-
-endothelial impact on the FMD test.
Statistical analysis
Categorical variables are presented with absolute and
relative frequency and distribution compared with Chi-
-square test. Continuous variables are expressed as mean
±standard deviation because the distribution was normal
(p>0.05; Kolmogorov-Smirnov test). Differences between
groups were examined with independent t-tests. Repea-
ted measures ANOVA models were used to assess wi-
thin-group differences in FMD percentage change for the
experimental group. The association of variables was cal-
culated with Pearson’s correlation coefficient.
The level of significance for which conclusions were
considered statistically significant was p<0.05. The anal-
yses were performed with MedCalc 11.2.0.0. (Medcalc
Inc, Mariakerke, Belgium) and Statistica 9.1 (Statsoft
Inc, Tulsa, USA).
Results
Prior to the total knee replacement patients had a sig-
nificantly lower FMD percentage change than healthy
examinees, although absolute values of the test were
within the normal range (Figure 1) in both groups. In all
patients the initial FMD percentage change was nega-
tively connected with the body weight (r=–0.43; p=
0.006), however, it did not show a significant connection
with the values of blood pressure, cholesterol and glyco-
lised hemoglobin, or with the taking of beta-blockers,
statins or ACE-inhibitors (all p>0.05). None of these car-
diovascular risk factors was connected with with the
changes of FMD percentage during the research. The
values of NMD test did not vary between groups (p=
0.430; 13.8±9.1 vs. 15.1±5.3), while pathological values of
this measurement were not recorded in any single exa-
minee included in the research. During the study, we did
not record clinical, electrocardiograph or laboratory (in-
crease in troponin I) elements for the development of
acute cardiovascular complications.
The post-operative serial FMD testings showed a sig-
nificant transitory damage of the endothelial function in
the first week after the surgical intervention. The post-
-operative dynamic of the FMD percentage change sho-
wed »U-shape« dynamics, values were progressively low-
ered during the first 24 hours after the surgery, after
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TABLE 1
PATIENTS’ CHARACTERISTICS
X±SD
pExperimental
N=19
Control
N=20
Age (y) 71±6 69±5 0.143
Height (cm) 168±8 172±10 0.229
Weight (kg) 84±11 81±11 0.330
Cholesterol (mmol/L) 5.2±1.0 4.2±0.6 0.001
RRd* 82±9 77±11 0.110
RRs** 146±10 134±16 0.006
*RRd – diastolic blood pressure; **RRs – systolic blood pressure
which they began to increase gradually until the seventh
day when (FMD 1 vs. FMD 6; p>0.05) they reached the
initial values (Figure 2).
With the pairwise comparison analysis we obtained sig-
nificant differences between FMD 3 and FMD 6 (6.6±3.4 vs.
10.4±2.3; p=0.022).
Discussion and Conclusion
The decreased ability of the brachial artery in FMD
test to dilate upon the controlled outside stimulus in the
early period after the major orthopaedic surgery indi-
cates the decrease in the capacity for endogenous NO
production. The decreased availability of this most sig-
nificant intermediary and marker of endothelial function
indicates the development of ED, which is transitory ac-
cording to our results, becoming worse during the first
post-operative day, reaching its peak 24 hours after the
operation, after that regressing in the first week, all until
the seventh day when it normalises spontaneously. Alt-
hough the FMD test quantifies the vasodilatation capa-
bility of the periferial artery, the known body unity of en-
dothelial function tells us that this examination perfectly
correlates with the endothelial function of coronary ar-
teries25,27. The FMD test has a predictive power of 95%
for the detection of the pathologic coronary angiogram
(14), as well as a better specific quality in the detection of
myocardial ischemia than the classic ergometric test28,
while it is also significant that this method of assessing
endothelial function proves to have an obvious capability
to predict acute vascular events29. Thus the transitory
ED described in our research can present one of the im-
portant mechanisms of the development of post-opera-
tive ACS as the most significant cardiovascular complica-
tion in orthopaedic surgery today, having a significant
impact on the overall outcome of the treatment24.
It is from the continuation of this subject matter re-
search that we expect to have the confirmation for this
hypothesis based on the before-mentioned facts. Although
it is indisputable that additional investigation is needed
for the confirmation of results that we have presented, it
is also necessary for them to be examined in other types
of surgical interventions, accompanied by a long-term
prospective surveillance in order to have a precise assess-
ment of the predictive capability of FMD test in different
phases before and after the surgical intervention. Fur-
ther studies will have to raise the issue of examining the
possibility of therapy modification of the post-operative
ED that we have described. The testing of medication
which we know to be efficient in the therapy of chronic
ED (beta-blockers, statins, ACE-inhibitors) regarding the
perioperative dynamics of the endothelial function and
the long-term outcome, appears to be a challenging field
whose research is of a primary necessity21.
Although our results suggest the existence of differ-
ences in initial FMD test between patients that have to
undergo the total knee replacement and healthy exami-
nees of the adequate age and gender, there are some limi-
tations in the interpretation that have to be discussed
and taken into account in further research. Even though
the established total cholesterol levels are not of clinical
significance, the examined group has statistically signifi-
cantly higher values. Prior to the surgical intervention,
the group of patients also showed higher absolute values
of body weight and systolic and diastolic blood pressure,
although these differences do not express a statistical
significance. Knowing specific lifestyles and total health
status of patients with severe arthrosis of the knee who
are candidates for the total knee replacement surgery, we
could connect these differences with their significantly
reduced physical activities and a strictly sedentary life-
style31,32. Furthermore, but also very important is the is-
sue of direct connection between limited physical activity
with endothelial function and/or its direct connection
based on the adverse profile of classic cardiovascular risk
factors in orthopaedic patients. Although the eventual
testing of these impacts will require great efforts in re-
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Fig. 1. Differences in FMD percentage change between experimen-
tal and control group (p=0.02; 11±6.7 vs. 15.7±5.3)
Fig. 2. Differences in FMD percentage change in patients that
underwent major orthopaedic surgery with regard to post-opera-
tive course (p=0. 008).
search studies that follow, their results could provide sig-
nificant data to our knowledge of endothelial function.
The confirmation of connectedness between the func-
tional status of endothelial and the functional status of the
locomotor system is a challenging idea with a clear basis in
literature30, definitely asking for a thorough research.
Soon after the discovery of ED as a key pathological
mechanism in vascular biology, we had the description of
the clear connection of persistent ED with almost all
classic cardiovascular risk factors as its long-term cau-
ses11. However, of a more recent date, acute instigators of
the occurrence or aggravation of ED have been descri-
bed. Thus, nowadays we know that a psychological or
physical stress, acute infection or another newly oc-
curred inflamed state, smoking, even an inappropriate
meal, can bring about the development of a sudden, gen-
eralised and non-selective endothelial dysfunction, the
complications of which depend on the intensity, length
and degree of existing atherosclerotic changes33,34. Al-
though surgical interventions, including orthopaedic ones,
undoubtedly present a major stressful event and a pow-
erful pro-inflammatory stimulus26, data on the dynamics
of perioperational endothelial function remain scarce. Its
changes in the period following the orthopaedic interven-
tions have not been investigated at all, just as is the case
with investigations of possible connectedness with the
development of perioperational cardiovascular events. It
is the major orthopaedic interventions that are an ideal
model for further trials to investigate the perioperative
endothelial function. We are talking about major surgical
interventions performed on the massive scale, the elec-
tive character of which enables optimal planning and ex-
ecution of prospective clinical studies. Besides their con-
tribution to the knowledge of general vascular biology,
the obtained results could probably be directly applicable
in the investigated group of patients, this being of great
public health significance. The early detection of endo-
thelial dysfunction as a risk factor and the correlated
possibility of decreasing post-operative complications in
major orthopaedic interventions that nowadays present
the greatest part of elective surgical interventions is a
challenging idea for the testing of which further trials
are necessary.
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UGRADNJA TOTALNE ENDOPROTEZE KOLJENA PRA]ENA JE TRANZITORNOM ENDOTELNOM
DISFUNKCIJOM
S A @ E T A K
Akutni koronarni sindrom (AKS) danas predstavlja vode}e postoperativne kardiovaskularne komplikacije, dok je
endotelna disfunkcija (ED) jedan od najva`nijih ~imbenika njegovog razvoja. Kroni~na ED osnova je postupnog razvoja
i progresije aterosklerotskih lezija, dok njeno akutno pogor{anje vodi razvoju akutnih komplikacija ateroskleroze –
razvoju AKS. Perzistentna ED nastaje pod djelovanjem razli~itih kroni~nih kardiovaskularnih rizi~nih ~imbenicima, ali
se prema ograni~enim dostupnim izvorima mo`e naglo razviti ili akutno pogor{ati pod djelovanjem razli~itih akutnih
doga|aja. U skladu s navedenim, predmetno je istra`ivanje usmjereno utvr|ivanju endotelnog funkcionalnog statusa
prije velike ortopedske kirur{ke operacije i njegove dinamike u ranom razdoblju nakon zahvata. Randomizirana pros-
pektivna studija uklju~ila je 19 bolesnika koji su podvrgnuti zahvatu ugradnje totalne koljenske endoproteze i 20 zdra-
vih ispitanika odgovaraju}e dobi i spola. Visokorezolucijski ultrazvu~ni test procjene endotelne funkcije temeljen koji
koristi protokom posredovanu dilataciju brahijalne arterije (FMD) izvodio se na po~etku ispitivanja, te 12, 24, 48 i 72
sata, kao i 7 dana nakon operativnog zahvata. Po~etne vrijednosti FMD-a bile su unutar referentnih raspona u obje
grupe, iako je sposobnost spontane dilatacije nakon naglog pove}anja protoka testiranom arterijom bila zna~ajno ni`a u
ispitivanoj skupini. Razina promjene FMD-indeksa u ukupnom je uzorku iskazala negativnu korelaciju s tjelesnom
te`inom, dok nije bila zna~ajno povezana s bilo kojim drugim klasi~nim kardiovaskularnim rizi~nim ~imbenikom. Tije-
kom ranog postoperativnog razdoblja, zabilje`eno je zna~ajno, ali prolazno smanjenje FMD-indeksa koji je najni`e ra-
zine dosegao 24 sata nakon operacije. Tijekom sedmodnevnog postoperativnog pra}enja u ispitivanoj skupini nismo
zabilje`ili razvoj zna~ajnih kardiovaskularnih komplikacija. Potrebna su daljnja istra`ivanja kako bi se potvrdili ovi
rezultati i istra`ila mogu}a povezanost opisane reaktivne postoperativne endotelne disfunkcije s razvojem kardiovasku-
larnih komplikacija i drugih ne`eljenih doga|aja.
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